TIL — Instil Bio, Inc.

—
Nasdaq · Health Care · Biotechnology · CIK 1789769 ·
Last close
$5.40
Market Cap
$36.62M
52W High
$13.50
52W Low
$5.17
ADV30
66,658
Next earnings
—

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGross profitOp incomeNet incomeAssetsCashLiabilities
Sep 2026 0 — -6,066,000 -4,231,000 195,645,000 2,544,000 93,081,000
Jun 2026 0 — -5,400,000 -4,299,000 197,712,000 5,541,000 90,332,000
Mar 2026 0 — -6,018,000 -4,204,000 200,428,000 5,022,000 89,730,000
Dec 2025 0 — -9,557,000 -8,191,000 203,523,000 6,638,000 89,657,000

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$-23,612,000
Investing CF
$21,239,000
Financing CF
$378,000
CapEx
—
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-6.50
As of
2026-11-15

Balance + Analyst (yfinance extras)

Retained Earnings
$-734,991,000
Inventory
—
Receivables
$26,000
ST Investments
$64,137,000
EBIT TTM
$-24,982,000
Pretax Income TTM
$-30,281,000
Interest Exp TTM
$5,299,000
Analysts
1

Annual Trend (SEC EDGAR, last 4y)

Revenues vs Net Income (last 4y)

FY endRevenuesOp incomeNet incomeAssetsLiabilitiesEquityOp cash flow
Dec 2025 0 -51,959,000 -71,372,000 203,523,000 89,657,000 113,866,000 -36,619,000
Dec 2024 0 -56,048,000 -74,135,000 263,567,000 94,131,000 169,436,000 -55,696,000
Dec 2023 0 -87,157,000 -156,087,000 325,630,000 99,801,000 225,829,000 -82,029,000
Dec 2022 0 -203,291,000 -223,177,000 482,128,000 118,523,000 363,605,000 -180,164,000

TTM Snapshot

Revenues TTM
$0
NetIncome TTM
$-30,281,000
OpCashFlow TTM
—
Assets (Latest)
$197,712,000
Forward EPS
$-14.64

Peers — same industry

TickerNameMarket CapLastDaily %
CRBU Caribou Biosciences, Inc. $36.81M $0.34 —
TVGN Tevogen Inc. $37.05M $5.69 —
BKHA Black Hawk Acquisition Corp $35.93M $8.65 —
ELUT ELUTIA INC. $37.91M $0.85 —
KLRS Kalaris Therapeutics, Inc. $34.04M $1.43 —

News headlines (Yahoo Finance, 1h cache)

Instil Bio Reports Third Quarter 2026 Financial Results and Provides Corporate Update
2026-11-16 12:00 · Yahoo
Instil Bio Reports First Quarter 2026 Financial Results and Provides Corporate Update
2026-05-15 11:00 · Yahoo
Instil Bio Reports Second Quarter 2026 Financial Results and Provides Corporate Update
2026-08-13 21:00 · Yahoo
Instil Bio Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update
2026-03-27 11:00 · Yahoo
CarMax Stock Down 47% This Past Year, But One Fund Is Betting $6 Million on a Turnaround
2026-02-03 15:20 · Yahoo
Alumis Stock Has Rallied 250% This Past Year. One Fund Sold Its $5 Million Stake Last Quarter.
2026-02-03 15:06 · Yahoo
Instil Bio’s Subsidiary Discontinues Clinical Development of AXN-2510 and Terminates License and Collaboration Agreement with ImmuneOnco
2026-01-06 12:00 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.